"We are pleased to launch our new logo and brand identity combined with a new comprehensive web site (www.corelabpartners.com) to the biopharmaceutical drug development sector", said CoreLab Partners’ president and CEO, Mike Woehler. "As we continue our integration of the RadPharm and Medifacts functional teams, CoreLabs’ is creating a global business model which provides an innovative suite of imaging sciences solutions combined with a full spectrum of cardiac safety services; a powerful business proposition as our sponsors seek to streamline their vendor partners and establish long-term strategic relationships going forward", added Woehler.

Science. Service. Technology.

The CoreLab Partners’ positioning includes the introduction of a new web site, distinct logo, new company tag line and refined mission statement designed to establish both a strong visual association with the company and effectively communicate a unique value proposition to the biopharmaceutical industry. CoreLab Partners’ new brand identity is being launched to coincide with the Partnerships in Clinical Trials Conference in Orlando, Florida. Key company executives will be on hand at stands #515, 539 to meet with the sponsor community to answer any questions and discuss their expanded suite of service solutions.